VIPomaSymptoms, Doctors, Treatments, Advances & More
Learn About VIPoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Century Medical & Dental Center
Anzhela Dvorkina is a Board Certified Internal Medicine physician with over 30 years of experience. Doctor Anzhela Dvorkina graduated from State University of New York Downstate Medical Center in the year 1983 and was awarded the doctor of medicine degree. Since then she has received numerous awards from local authorities in the state of New York. Dr. Dvorkina is currently working at Century Medical & Dental Center. Her main goal is to help her patients go through any health problems with dedicated support and professionalism. Dr. Dvorkina is rated as an Experienced provider by MediFind in the treatment of VIPoma. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidoses (MPS), Non-Alcoholic Fatty Liver Disease, High Cholesterol, and Obesity.
Detlef Bartsch practices practicing medicine in Marburg An Der Lahn, Germany. Bartsch is rated as a Distinguished expert by MediFind in the treatment of VIPoma. They are also highly rated in 26 other conditions, according to our data. Their clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Multiple Endocrine Neoplasia Type 1, Parathyroidectomy, and Pancreaticoduodenectomy.
Thomas Walter practices practicing medicine in Lyon, France. Mr. Walter is rated as a Distinguished expert by MediFind in the treatment of VIPoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, VIPoma, Carcinoid Syndrome, Liver Embolization, and Hepato-Pancreato-Biliary Surgery.
Summary: Multiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant disease with a high degree of penetrance (\>80% of patients). It is caused by the presence of the MEN1 mutation located on chromosome 11q13. The prevalence of this mutation is estimated at approximately 1/30,000. This hereditary syndrome is characterized by the presence of tumours of the endocrine system (adenoma of the parathyroi...